Life-Threatening Hypocalcemia with Denosumab;Anaphylaxis in Two Children Receiving Etanercept;Fondaparinux Hepatotoxicity in a 6-Year-Old Child;Bullous Pemphigoid Induced by Dipeptidyl Peptidase-4 Inhibitors;Severe Neuroleptic Malignant Syndrome with Deep Coma Associated with Aripiprazole;Quetiapine-Induced Tardive Oculogyric Crisis

Abstract

The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the US Food and Drug Administration's (FDA's) MedWatch program (800-FDA-1088). If you have reported an interesting, preventable ADR to MedWatch, please consider sharing the account with our readers.